Biotechnology and Cytotherapeutics: The Swiss Progenitor-Cell Transplantation Program

Biotechnology and Cytotherapeutics: The Swiss Progenitor-Cell Transplantation Program

Historically, primary human progenitor cells (e.g., WI-38 and MRC-5 diploid-cell sources) have been industrially applied in research and in manufacturing processes for vaccines and for biologicals. Furthermore, tissue-specific primary progenitor-cell banks have recently been developed and exploited...

Full description

Bibliographic Details
Main Authors: Alexis Laurent, Corinne Scaletta, Philippe Abdel-Sayed, Murielle Michetti, Anthony de Buys Roessingh, Wassim Raffoul, Nathalie Hirt-Burri, Lee Ann Applegate
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Encyclopedia
Subjects:
biotechnological substrates
cell therapies
organ donation
pharmacopeial monographs
progenitor cells
quality requirements
Online Access:https://www.mdpi.com/2673-8392/2/1/21

Internet

https://www.mdpi.com/2673-8392/2/1/21

Similar Items